Congratulations to Indianapolis-based Apexian Pharmaceuticals, a clinical-stage biotech company that is developing novel compounds to treat cancer. It commercializes intellectual property discovered at the Indiana University School of Medicine. Company officials announced that the U.S. Food and Drug Administration has agreed that APX3330, the company’s investigational new drug, can be used to examine chemotherapy-induced peripheral… Read more »
Entries by Steve Martin
Xylogenics, which commercializes IU intellectual property, reaches new milestone
Congratulations to Xylogenics, which released a new strain design for its yeast production and fermentation process. According to a company news release, the strain “is currently applicable within the fuel ethanol industry and will soon be available to markets as varied as pharmaceuticals, agriculture, enzymes and a variety of bio-based chemical products such as flavors,… Read more »
Indiana University expands, reorganizes technology transfer and licensing
The university has announced that it is expanding the resources devoted to delivering IU innovations to Indiana and the nation. Technology transfer activities have been moved into the Office of the Vice President for Research. These activities include receiving and vetting invention disclosures, applying for intellectual property protection, and marketing technologies and licensing them to… Read more »
Johnson Center for Innovation and Translational Research funds a total of nearly $100K to four projects
The Johnson Center for Innovation and Translational Research has awarded a total of nearly $100,000 through its Translational Research Pilot Grant program to four projects led by researchers at Indiana University Bloomington. Launched in 2015, the program supports the development of translational research projects with industry partners and the establishment of new companies, as well as… Read more »
Entrepreneurial faculty, students, staff and alumni at all IU campuses to get a boost
Indiana University-connected individuals with entrepreneurial aspirations — including faculty, students, staff and alumni across all campuses and academic disciplines — will have something to celebrate July 1 when the Indiana University Research and Technology Corp. undergoes a reorganization to address challenges to entrepreneurs. Through this reorganization, the new IURTC will be positioned to more efficiently… Read more »
June 2017 Insights e-newsletter now available
The Insights e-newsletter from Innovate Indiana is now available. Read more about innovation and economic development at Indiana University’s campus system here.
IURTC Outreach: Tony Armstrong to speak on technology transfer panels
In June, Tony Armstrong, president and CEO of the Indiana University Research and Technology Corp., will participate in two panel discussions about technology transfer. “The discussions will have similar content: how technology transfer offices have to evolve to support their local economy and university,” he said. “Technology transfer professionals must engage more deeply with industry… Read more »
Indiana Business Research Center develops tool for U.S. Economic Development Administration to assess innovation capacity
Indiana University’s Indiana Business Research Center has developed a new tool called Innovation Index 2.0, also known as II 2.0, to compare regions around the United States in the categories of economic dynamics, human capital, productivity and employment, and well-being. Development of II 2.0 was funded by the U.S. Economic Development Agency, which charges nothing… Read more »
Marie Kerbeshian on Indiana University inventions, technology commercialization and next steps
Marie Kerbeshian, vice president of technology commercialization, will be leaving Indiana University Research and Technology Corp. this week. She wrote the following for the Crimson Catalyst blog. “You may be familiar with the term ‘medical students’ disease,’ when students worry they are exhibiting the exact symptoms they are studying in class. Sometimes I jest that as… Read more »
Representatives from Japanese pharmaceutical company that licenses IU discovery meet with IURTC, IU School of Medicine researchers
On April 27, representatives from Tokyo-based Kyowa Hakko Kirin Co. Ltd., known as Kirin, which licenses intellectual property discovered at the IU School of Medicine, met with the researchers and representatives of the IU Research and Technology Corp. Jun Arakawa and Yoshihiro Furuya, managers at the company, provided an update about its business and the… Read more »